Clinical outcome and service implications of screening women at increased breast cancer risk from a family history

European Journal of Surgical Oncology

Volumn 32, Issue 7, 2006, Pages 719-724

  Gui, G P H ^a   Kadayaprath, G ^a   Darhouse, N ^a   Self, J ^a   Ward, A ^a   A'Hern, R ^a   Eeles, R ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Breast cancer risk; Breast cancer services; Breast screening; Family history

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; BREAST TUMOR; CANCER RISK; CANCER SCREENING; CLINICAL EXAMINATION; CONTROLLED STUDY; EARLY DIAGNOSIS; FAMILY HISTORY; FEMALE; FOLLOW UP; HEALTH PROGRAM; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; OUTCOME ASSESSMENT; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RECALL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; UNITED KINGDOM;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; RISK FACTORS;

EID: 33747795931     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2006.05.002     Document Type: Article

References (37)

1. Easton D., and Peto J. The contribution of inherited predisposition to cancer incidence. Cancer Surv 9 (1990) 395-416
2. Claus E.B., Risch N., and Thompson W.D. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 48 (1991) 232-242
3. Easton D.F., Ford D., and Bishop D.T. Breast Cancer Linkage Consortium, breast and ovarian cancer incidence in BRCA-1 mutation carriers. Am J Hum Genet 56 (1995) 265-271
4. Struewing J.P., Hartge P., Wacholder S., et al. The risk of cancer associated with specific mutations of BRCA-1 and BRCA-2 among Ashkenazi Jews. N Engl J Med 336 (1997) 1401-1408
5. Thorlacius S., Struewing J.P., Hartge P., et al. Population-based study of risk of breast cancer in carriers of BRCA-2 mutations. Lancet 352 (1998) 1737-1739
6. Eccles D.M., Evans D.G., and Mackay J. Guidelines for a genetic risk based approach to advising women with a family history of breast cancer. UK Cancer Family Study Group (UKCFSG). J Med Genet 37 (2000) 203-209
7. Sauven P. Association of Breast Surgery Family History Guidelines Panel. Guidelines for the management of women at increased familial risk of breast cancer. Eur J Cancer 40 (2004) 653-665
8. Familial breast cancer. The classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care. National Institute of Clinical Excellence (NICE) guidelines 2004 (2004), Hobbs, London 1-9. www.nice.org.uk/CG014NICEguideline
9. Lloyd S., Watson M., Waites B., et al. Familial breast cancer: a controlled study of risk perception, psychological morbidity and health beliefs in women attending for genetic counselling. Br J Cancer 74 (1996) 482-487
10. Lerman C., Lustbader E., Rimer B., et al. Effects of individualised breast cancer risk counselling: a randomised trial. J Natl Cancer Inst 87 (1995) 286-292
11. Hopwood P., Keeling F., Long A., Pool C., Evans G., and Howell A. Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators. Psychooncology 7 (1998) 402-412
12. Kollias J., Sibbering R.W., Blamey R.W., et al. Screening women less than 50 years with a family history of breast cancer. Eur J Cancer 34 (1998) 878-883
13. Lalloo F., Boggis C.R.M., Evans D.G.R., Shenton A., Threlfall A.G., and Howell A. Screening by mammography, women with a family history of breast cancer. Eur J Cancer 34 (1998) 937-940
14. MacMillan R.D. Screening women with a family history of breast cancer - results from the British Familial Breast Cancer Group. Eur J Surg Oncol 26 (2000) 149-152
15. Gui G.P.H., Hogben R.F.K., Walsh G., A'Hern R., and Eeles R. The incidence of breast cancer from screening women according to predicted family history risk: does annual clinical examination add to mammography. Eur J Cancer 37 (2001) 1668-1673
16. Fletcher S.W., Black W., Harris R., Ramer B.K., and Shapiro S. Report of the international workshop on screening for breast cancer. J Natl Cancer Inst 85 (1993) 1644
17. Antman K., and Schea S. Screening mammography under age 50. JAMA 281 (1999) 1470-1472
18. Olsen O., and Gotzsche P.C. Cochrane review on screening for breast cancer with mammography. Lancet 358 (2001) 1340-1342
19. Miller A.B., To T., Baines C.J., and Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of in women aged 50-59 years. Ann Intern Med 137 (2002) 305-312
20. Freedman D.A., Petitti D.B., and Robins J.M. On the efficacy of screening for breast cancer. Int J Epidemiol 33 (2004) 43-55
21. .
22. Burke W., Daly M., Garber J., et al. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA 277 (1997) 997-1003
23. Lucassen A., Watson E., Harcourt J., Rose P., and O'Grady J. Guidelines for referral to a regional genetics services: GP's respond by referring more appropriate cases. Fam Pract 18 (2001) 135-140
24. Emery J., Murphy M., and Lucassen A. Heritage free cancer - the evidence for current recommended management. Lancet Oncol (2000 May) 9-16
25. Patnick J. NHS Breast Screening Programme - review 1994. In: The House of Commons Health Select Committee Report into Breast Cancer Services. 1994.
26. Quality assurance guidelines for breast screening radiology. In: Liston J, Wilson R, editors. National Health Breast Screening Programme (NHSBSP), publication number 59. 2005.
27. Elmore J.G., Wells C.K., Howard D.H., and Finstein A.R. The impact of clinical history on mammographic interpretation. JAMA 277 (1997) 49-52
28. Whitehouse P.A., Baber Y., Brown G., Moskovic E., King D.M., and Gui G.P.H. The use of ultrasound by breast surgeons in outpatients: an accurate extension of clinical diagnosis. Eur J Surg Oncol 27 (2001) 611-616
29. Brain K., Gray J., Norman P., et al. Randomised trial of a specialist genetic assessment service for familial breast cancer. J Natl Cancer Inst 92 (2000) 1345-1351
30. Gray J., Brain K., Norman P., et al. A model protocol evaluating the introduction of genetic assessment for women with a family history of breast cancer. J Med Genet 27 (2000) 192-196
31. Ong G., Austoker J., Brett J., Boyce A., Jepson C., and Ingstrom P.F. Breast screening: adverse psychological consequences one month after placing women on early recall because of a diagnostic uncertainty. A multi-centre study. J Med Screen 4 (1997) 158-168
32. Brett J., Austoker J., and Ong G.J. Do women who undergo further investigation for breast screening suffer adverse psychological consequences? A follow-up multi-centre study comparing different breast screening result groups five months after their last breast screening appointment. J Public Health Med 20 (1998) 396-403
33. Lerman C., Trock B., Rimer B.K., Boyce A., Jepson C., and Ingstrom P.F. Psychological and behavioural implications of abnormal mammograms. Ann Intern Med 114 (1991) 657-661
34. Olsson P., Armelius K., Nordahl G., Lenner P., and Westman G. Women with false positive screening mammograms; how do they cope?. J Med Screen 6 (1999) 89-93
35. Gilbert F.J., Cordiner C.M., Affleck I.R., Hood D.B., Mathieson D., and Walker L.G. Breast screening: the psychological sequelae of false-positive recall in women with and without family history of breast cancer. Eur J Cancer 34 (1998) 2010-2014
36. Brett J., Bankhead C., Henderson B., Watson E., and Austoker J. The psychological impact of mammographic screening. A systematic review. Psychooncology 14 (2005) 917-938
37. Raffle A.E. Informed participation in screening is essential. Br Med J 314 (1997) 1760-1763